A medication that slows bone loss; from a class of drugs known as bisphosphonates. As Fosamax, it has US Food and Drugs Administration approval for treating and preventing osteoporosis in women. It is also approved for treatment in men
a bone resorption inhibiting drug that slows or halts the loss of bone due to osteoporosis, marketed by Merck as Fosamax
a bisphosphonate drug, available as Fosamax ® , used to treat and prevent osteoporosis
Alendronate (Fosamax®, Merck) is a bisphosphonate drug used for osteoporosis and several other bone diseases. It is marketed alone as well as in combination with vitamin D (2,800 U, under the name Fosavance).